Cargando…

The Role of Procalcitonin Levels in Assessing the Severity of Clostridium Difficile Infection

Detalles Bibliográficos
Autores principales:	Dazley, Jason, Shaaban, Hamid, Afridi, Shoaib, Slim, Jihad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557143/ https://www.ncbi.nlm.nih.gov/pubmed/26392722 http://dx.doi.org/10.4103/0974-777X.162229

Ejemplares similares

Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
por: Shah, Nihar, et al.
Publicado: (2014)

Hepatitis A Vaccine Response in Human Immunodeficiency Virus-infected Patients: The Interchangeability of Single Dose versus Double: A Prospective Look
por: Dazley, Jason, et al.
Publicado: (2016)

Procalcitonin Levels Associate with Severity of Clostridium difficile Infection
por: Rao, Krishna, et al.
Publicado: (2013)

Pulmonary Embolism and Increased Levels of D-Dimer in Patients with Coronavirus Disease
por: Chan, Kok Hoe, et al.
Publicado: (2020)

Role of Single Procalcitonin Test on Admission as a Biomarker for Predicting the Severity of Clostridium difficile Infection
por: Hamo, Zohar, et al.
Publicado: (2017)

Idiopathic Granulomatous Mastitis as a Complication of Interferon-alpha Therapy
por: Shaaban, Hamid, et al.
Publicado: (2012)

Assessment of Reporting Bias for Clostridium difficile Hospitalizations, United States
por: Zilberberg, Marya D.
Publicado: (2008)

Clostridium difficile in Ground Meat, France
por: Bouttier, Sylvie, et al.
Publicado: (2010)

Clostridium difficile in Discharged Inpatients, Germany
por: Vonberg, Ralf-Peter, et al.
Publicado: (2007)

Compared lethality rates of Clostridium difficile infections at the local, regional and national levels in France
por: Huart, M., et al.
Publicado: (2016)

Attributing Cause of Death for Patients with Clostridium difficile Infection
por: Gilca, Rodica, et al.
Publicado: (2012)

Community-Acquired Clostridium difficile Infection, Queensland, Australia
por: Furuya-Kanamori, Luis, et al.
Publicado: (2016)

Clostridium difficile Surveillance Trends, Saxony, Germany
por: Burckhardt, Florian, et al.
Publicado: (2008)

Epidemic Clostridium difficile Ribotype 027 in Chile
por: Hernández-Rocha, Cristian, et al.
Publicado: (2012)

Clostridium difficile Infection Caused by Binary Toxin–Positive Strains
por: Hensgens, Marjolein P.M., et al.
Publicado: (2013)

Tranexamic Acid: A Potential Treatment Option for Coronavirus Disease 2019
por: Chan, Kok Hoe, et al.
Publicado: (2020)

Increasing Incidence of Clostridium difficile-associated Disease, Singapore
por: Lim, Poh Lian, et al.
Publicado: (2008)

Clostridium difficile–associated Disease in the Elderly, United States
por: Jagai, Jyotsna, et al.
Publicado: (2009)

Epidemic Clostridium difficile Strain in Hospital Visitation Dog
por: Lefebvre, Sandra L., et al.
Publicado: (2006)

Hypervirulent Clostridium difficile ribotypes are CpG depleted
por: Kamuju, Vinay, et al.
Publicado: (2018)

Time to Place Clostridium difficile Infections in Major Healthcare-associated Infections List
por: Sinha, Sharmili, et al.
Publicado: (2023)

Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006
por: Vindigni, Stephen M., et al.
Publicado: (2010)

Estimated incidence of Clostridium difficile infection.
por: Frost, F, et al.
Publicado: (1999)

Clostridium difficile–related Hospitalizations among US Adults, 2006
por: Zilberberg, Marya D.
Publicado: (2009)

Does the Influenza Vaccine Prevent Sequelae Such as Myocarditis from Developing?
por: Whitney, Ryan, et al.
Publicado: (2015)

Clindamycin-Resistant Clone of Clostridium difficile PCR Ribotype 027, Europe
por: Drudy, Denise, et al.
Publicado: (2008)

gyrA Mutations in Fluoroquinolone-resistant Clostridium difficile PCR-027
por: Drudy, Denise, et al.
Publicado: (2007)

Clostridium difficile Infection Associated with Pig Farms
por: Keessen, Elisabeth C., et al.
Publicado: (2013)

Clostridiodes difficile in COVID-19 Patients, Detroit, Michigan, USA, March–April 2020
por: Lakkasani, Saraswathi, et al.
Publicado: (2020)

Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?
por: Olmedo, Maria, et al.
Publicado: (2019)

Surface Layer Protein A Variant of Clostridium difficile PCR-Ribotype 027
por: Spigaglia, Patrizia, et al.
Publicado: (2011)

Clostridium difficile outcomes difficult to generalize
por: Nagella, Naresh, et al.
Publicado: (2013)

Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2017)

Fecal microbiota transplantation is feasible even in critically ill patients with toxic megacolon due to Clostridium difficile infection
por: Zybura, Joanna, et al.
Publicado: (2020)

The clinical usefulness of serum procalcitonin level in patients with scrub typhus
por: Lee, Chang-Seop, et al.
Publicado: (2017)

Serum procalcitonin in sepsis
por: Wiwanitkit, Viroj
Publicado: (2011)

The Largest American Study Comparing Transient Elastography and the Aminotransferase-to-platelet Ratio Index Score, Two Noninvasive Tests for Liver Fibrosis Staging in HIV/HCV Coinfected Patients
por: Dazley, Jason, et al.
Publicado: (2019)

The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)

Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
por: Abdehagh, Mohammad, et al.
Publicado: (2021)

Clostridium difficile Infection
por: Feuerstadt, Paul
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q89bbf2n4soa0k2p4e4phhlcsu